<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="100916">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02020759</url>
  </required_header>
  <id_info>
    <org_study_id>1557/2013</org_study_id>
    <nct_id>NCT02020759</nct_id>
  </id_info>
  <brief_title>Neurological Monitoring During Extracorporeal Membrane Oxygenation</brief_title>
  <official_title>Multimodal Neurological Monitoring in Patients Undergoing Extracorporeal Membrane Oxygenation (ECMO) - a Prospective Observational Pilot Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <authority>Austria: Ethikkommission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Neurological complications are frequent during extracorporeal membrane oxygenation (ECMO)
      representing a crucial factor for patient outcome. However, to date there is no consensus
      with regard to optimal neurological monitoring of patients undergoing ECMO.

      The aim of this study is to monitor patients using transcranial Doppler (TCD) ultrasound and
      near-infrared spectroscopy (NIRS) during ECMO therapy.

      The study hypothesis is that TCD and NIRS technology are sufficient tools to detect cerebral
      embolism and hypoperfusion during ECMO therapy.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Anticipated">May 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Cerebral embolic load</measure>
    <time_frame>30 minutes</time_frame>
    <safety_issue>No</safety_issue>
    <description>Cerebral embolic load (solid and gaseous) is measured in a 30 minutes-interval during ECMO usage</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Regional cerebral oxygenation</measure>
    <time_frame>30 minutes</time_frame>
    <safety_issue>No</safety_issue>
    <description>Regional cerebral oxygenation is measured in a 30 minutes-interval during ECMO usage.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Complication of Extracorporeal Membrane Oxygenation</condition>
  <condition>Cerebral Embolism</condition>
  <condition>Cerebral Hypoperfusion</condition>
  <arm_group>
    <arm_group_label>Patient on ECMO</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Neurological monitoring</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcranial Doppler Ultrasound</intervention_name>
    <description>Transcranial Doppler Ultrasound is used to monitor cerebral embolism Near-Infrared Spectroscopy is used to detect cerebral hypoperfusion</description>
    <arm_group_label>Patient on ECMO</arm_group_label>
    <other_name>Near-Infrared Spectroscopy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ECMO Therapy due to respiratory or cardiac failure

          -  Age &gt; 18 yrs.

          -  Signed informed consent

        Exclusion Criteria:

          -  Inclusion in an other clinical study

          -  Gravidity

          -  Cerebral disease of any cause (e.g. intracerebral hemorrhage, stroke)

          -  Sepsis and related conditions affecting the brain (septic cerebral embolism)

          -  Allergy against materials of one of the medical device used in the study
             (transcranial Doppler, Near- infrared spectroscopy)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gabor Erdoes, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Vienna</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gabor Erdoes, MD</last_name>
    <phone>0043 1 40400</phone>
    <phone_ext>4102</phone_ext>
    <email>erdoesgabor@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ulrich Klein, MD</last_name>
    <phone>0043 1 40400</phone>
    <phone_ext>4102</phone_ext>
    <email>ulrich.klein@meduniwien.ac.at</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medical University of Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gabor Erdoes, MD</last_name>
      <phone>0043 40400</phone>
      <phone_ext>4102</phone_ext>
      <email>erdoesgabor@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Klaus Markstaller, Md, PhD</last_name>
      <phone>0043 40400</phone>
      <phone_ext>4102</phone_ext>
      <email>klaus.markstaller@meduniwien.ac.at</email>
    </contact_backup>
    <investigator>
      <last_name>Gabor Erdoes, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 24, 2013</lastchanged_date>
  <firstreceived_date>December 19, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Dr. Gabor Erdoes</investigator_full_name>
    <investigator_title>Dr Gabor Erdoes</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Intracranial Embolism</mesh_term>
    <mesh_term>Embolism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
